A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Urheber
-
Jensen, K.
- Beteiligte Personen und Organisationen
-
Ranganathan, UD
Kozlowski, P.
Van Rompay, K.
Canfield, D.
Ravindran, R.
Khan, I.
Luciw, P.
Fennelly, G.
Larsen, M.
Abel, K.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-O4
- URN
-
urn:nbn:de:1111-2016080724463
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jensen, K.
- Ranganathan, UD
- Kozlowski, P.
- Van Rompay, K.
- Canfield, D.
- Ravindran, R.
- Khan, I.
- Luciw, P.
- Fennelly, G.
- Larsen, M.
- Abel, K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
SiV
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
No evidence for ongoing replication on ART in SIV-infected macaques
Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
SiV
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
No evidence for ongoing replication on ART in SIV-infected macaques
Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
SiV
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
No evidence for ongoing replication on ART in SIV-infected macaques